Prevention of nephrotoxicity by megalin receptor saturation is a nephroprotective strategy that appears to have interesting results in nuclear medicine by reducing the incidence of renal failure in somatostatin metabolic radiotherapy.[19] Digestive tolerance remains poor, and cilastatin could be an attractive future alternative. The gene discussed is SST; the disease is Renal insufficiency.